TranS1 is a medical device company that specializes in innovative solutions for spinal surgery, focusing on minimizing the trauma associated with traditional surgical methods. One of their key products is the AxiaLIF+ (Axial Lumbar Interbody Fusion) System, which provides a safe and reproducible access route to the L5-S1 vertebral bodies through an anterior retroperitoneal pre-sacral approach. This technology aims to enhance surgical precision while reducing the potential for damage to surrounding tissues, thereby improving patient outcomes.

In addition to the AxiaLIF+ System, TranS1 offers the Vectre™ Facet Fusion System, which is designed for posterior fixation. This system utilizes a cannulated facet screw that is inserted over a guidewire, further minimizing muscle and tissue trauma during the procedure. By providing these advanced surgical tools, TranS1 aims to support surgeons in delivering effective spinal interventions while also enhancing recovery times for patients.

United States

TranS1 is a pioneer in spine technology innovation and is focused on Building Better Pathways™ to the spine. Since its inception, TranS1 has designed, developed, and commercialized transformational approaches to the spine used by thousands of surgeons to minimize the damage associated with traditional surgical approaches. TranS1 believes that the process of Building Better Pathways™ to the spine starts with solving true unmet clinical needs and ends with creating a value-based solution for surgeons, patients, and the healthcare system. trans1.com/ifu MKT-52205.A

TranS1 (2)

Company Details